Philips and Ibex expand partnership to enhance AI-enabled pathology workflows for better patient care

Portfolio CompaniesLIP Fund II
Written By Federico de Mateo

Royal Philips, a global leader in health technology, today announced the expansion of its partnership with Ibex Medical Analytics (Ibex) and a new release of Philips IntelliSite Pathology Solution (PIPS) to further accelerate the adoption of AI-enabled digital pathology to address the pressure pathologists face because of the global shortage of pathologists and the growing number of cancer patients. Following the start of the partnership in 2021, Philips and Ibex can now offer even further interoperability of its solutions, aiming to enhance diagnostic workflows for clinicians and enabling better care for more people.

Ibex's AI and Philips’ digital pathology solution have shown to improve reporting efficiency and drive productivity gains of up to 37% [1]. Through this partnership, pathology laboratories are able to utilize PIPS, which includes the full portfolio of scanners and Image Management System, and Ibex’s platform of AI-powered tools for prostate, breast and gastric cancer diagnostics.

Federico de Mateo
Previous

DailyPay Expands Its Platform For Employees to Access Federal Tax Returns 5 Days Early
Next

Presenting Tabnine + Dell AI Factory—a powerful, enterprise-grade AI software development solution deployable on-premises with Dell PowerEdge servers and NVIDIA GPUs.